The pharmaceutical industry in Jordan is regulated by the Ministry of Health (‘MoH’), and supervised by the Jordanian Food and Drug Association (‘JFDA’). Under the auspices of the MoH and the JFDA, a myriad of local laws regulate the pharmaceutical sector, including those governing the import of medical products and registration requirements. In this article, we examine the impact of transferring the marketing authorisation holder (‘MAH’) status to a new legal entity. 